CCMH
FRTX

Cornerstone Capital Management Holdings’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-11
Closed -$13K – 1512
2016
Q1 		$13K Sell
11
-12
-52% -$13.8K ﹤0.01% 1460
2015
Q4 		$30K Hold
23
– – ﹤0.01% 1396
2015
Q3 		$33K Hold
23
– – ﹤0.01% 1442
2015
Q2 		$50K Sell
23
-6
-21% -$18.8K ﹤0.01% 1359
2015
Q1 		$86K Sell
29
-8
-22% -$25.6K ﹤0.01% 1278
2014
Q4 		$123K Sell
37
-5
-12% -$17.7K ﹤0.01% 1142
2014
Q3 		$147K Buy
42
+21
+100% +$81.6K ﹤0.01% 1136
2014
Q2 		$82K Buy
+21
New +$79K ﹤0.01% 1200

Other funds holding FRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
CAM
ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $3.02B AUM 34.37% 1-Year Est. Return

Cornerstone Capital Management Holdings's FRTX Position: Q2 2016 in Review

Cornerstone Capital Management Holdings sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q2 2016, closing a stake of 11 shares — an estimated $13K sold.

Cornerstone Capital Management Holdings first reported a position in FRTX in Q2 2014 and held it in 8 quarters. The position peaked at $147K in Q3 2014. 36 funds tracked by Wall St. Rank hold FRTX as of Q2 2016.

  • Cornerstone Capital Management Holdings reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
  • Cornerstone Capital Management Holdings sold 11 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q2 2016, an estimated $13K.
  • Cornerstone Capital Management Holdings first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2014 and held it in 8 quarters.
  • Cornerstone Capital Management Holdings's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $147K in Q3 2014.
  • 36 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q2 2016.

Based on Cornerstone Capital Management Holdings's 13F filing for Q2 2016, filed 12 Aug 2016.